Results 141 to 150 of about 1,179,318 (342)
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia +17 more
wiley +1 more source
REPLICA PLATING AND INDIRECT SELECTION OF BACTERIAL MUTANTS [PDF]
, 1952 Joshua Lederberg, Esther M. Lederberg
openalex +1 more source
Molecular Oncology, EarlyView.Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
The Moran process on a random graph [PDF]
arXivWe study the fixation probability for two versions of the Moran process on the random graph $G_{n,p}$ at the threshold for connectivity. The Moran process models the spread of a mutant population in a network. Throughtout the process there are vertices of two types, mutants and non-mutants. Mutants have fitness $s$ and non-mutants have fitness 1.
arxiv
A Haploid Mutant in the Jimson Weed, " Datura stramonium " [PDF]
, 1922 A. F. Blakeslee +3 more
openalex +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
Molecular Oncology, EarlyView.We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian +12 more
wiley +1 more source
On Accelerating Deep Neural Network Mutation Analysis by Neuron and Mutant Clustering [PDF]
arXivMutation analysis of deep neural networks (DNNs) is a promising method for effective evaluation of test data quality and model robustness, but it can be computationally expensive, especially for large models. To alleviate this, we present DEEPMAACC, a technique and a tool that speeds up DNN mutation analysis through neuron and mutant clustering ...
arxiv
STUDIES OF A PURINE- OR HISTIDINE-REQUIRING MUTANT OF ESCHERICHIA COLI
, 1955 D. Luzzati, Robert Guthrie
openalex +1 more source
Molecular Oncology, EarlyView.MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin +14 more
wiley +1 more source